XOMA Corp (NASDAQ:XOMA)

26.16
Delayed Data
As of Feb 23
 +0.81 / +3.20%
Today’s Change
4.50
Today|||52-Week Range
37.25
-26.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$213.0M

Company Description

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Berkeley, CA.

Contact Information

XOMA Corp.
2910 Seventh Street
Berkeley California 94710
P:(510) 204-7200
Investor Relations:
(510) 204-7482

Employees

Shareholders

Mutual fund holders7.97%
Other institutional34.93%
Individual stakeholders1.00%

Top Executives

James R. NealChief Executive Officer & Director
Thomas BurnsCFO, Principal Accounting Officer & VP-Finance
F. Allan GordonVice President-Clinical
Danny J. HartVice President & General Counsel
Dee DattaChief Business Officer